Acarix AB (publ) publishes Interim Report, April – June 2024
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the second quarter of 20...
Acarix AB (publ) publishes Interim Report, April – June 2024
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the second quarter of 20...
Acarix AB (publ) publishes Interim Report, January – March 2024
Setting the stage for a strong 2024 and beyond
One of the most notable achievements this quarter has been the successful implementation...
Acarix AB (publ) publicerar Bokslutskommuniké 2023
Fokus mot USA och hållbar tillväxt
Som nyutnämnd VD är jag hedrad att få leda Acarix och dela en del av våra vision för framtiden. Foku...
Acarix AB (publ) publishes Year-End Report 2023
Embarking on a new journey with focus on sustainable growth
As the newly appointed CEO of Acarix, I am honored to be on board and share...
Acarix AB (publ) publishes Interim Report, July – September 2023
Continued momentum in the US and strengthened financing in place
We are pleased with the Q3 revenue growth in the US, where we are maki...
Acarix AB (publ) publicerar delårsrapport, juli – september 2023
Fortsatt momentum i USA och stärkt finansiering på plats
Vi är nöjda med intäktstillväxten i USA under Q3, där vi gör betydande investe...
Acarix AB (publ) publishes Interim Report, April – June 2023
Traction in the US market reflects transition to a new expanded commercial model
In 2022, we initiated the transition of Acarix to full...
Acarix AB (publ) publicerar delårsrapport, april – juni 2023
Dragkraft på den amerikanska marknaden återspeglar övergången till en ny kommersiell modell
Under 2022 påbörjades omställningen av Acar...
Acarix AB (publ) publishes Interim Report, January – March 2023
2023 is off to a good start
In the first quarter of 2023 our strategy delivered important results with a breakthrough order from the la...
Acarix AB (publ) publicerar delårsrapport, januari – mars 2023
2023 har börjat bra
Under första kvartalet 2023 levererade vi viktiga delresultat med en genombrottsorder från den största vårdgivaren ...
Acarix AB (publ) publishes Year-End Report 2022
Strategic shift towards full commercial focus on the US market now in place
As we sum up 2022, it becomes clear that Acarix has in a sh...